Mitochondrial Open Reading Frame of the 12S rRNA-c
A mitochondrial-derived peptide encoded within mitochondrial DNA that functions as a metabolic regulator, activating AMPK, improving insulin sensitivity, supporting fat oxidation and demonstrating exercise-mimicking effects in published research.
MOTS-c is a 16 amino acid peptide encoded within the mitochondrial genome — specifically within the 12S ribosomal RNA gene. It was identified in 2015 by Dr. Changhan Lee and colleagues at USC, making it a relatively recently characterised compound. It is naturally produced by mitochondria and circulates in the bloodstream, acting as a hormone-like metabolic regulator.
The fact that MOTS-c is encoded in mitochondrial DNA rather than nuclear DNA is unusual and suggests it evolved as a retrograde signal — a way for mitochondria to communicate their metabolic status to the rest of the body.
MOTS-c's primary mechanism involves translocation to the nucleus where it activates AMPK (AMP-activated protein kinase) — often called the body's "master metabolic switch." AMPK activation has widespread metabolic effects including increased glucose uptake in muscle, enhanced fat oxidation, improved insulin sensitivity and activation of mitochondrial biogenesis (production of new mitochondria).
MOTS-c also regulates folate and methionine metabolism, and has been shown to accumulate in skeletal muscle in response to exercise — suggesting it is part of the natural signalling cascade that produces exercise's metabolic benefits.
Rodent studies have shown that MOTS-c administration produces metabolic effects similar to exercise — including increased endurance capacity, improved glucose handling and body fat reduction — even in sedentary animals. This "exercise mimicking" effect has attracted significant research interest for its potential applications in metabolic disease, aging and physical performance.
MOTS-c levels naturally decline with age, and lower MOTS-c levels have been associated with metabolic dysfunction and age-related disease. Studies in aging mice have demonstrated that MOTS-c supplementation reverses age-related metabolic decline, improves insulin sensitivity and extends healthspan. Centenarian studies have found associations between MOTS-c genetic variants and exceptional longevity.
MOTS-c, SS-31 and NAD+ form a natural synergistic triad for mitochondrial health — each targeting a different aspect of mitochondrial function. SS-31 protects the structural integrity of the inner membrane; NAD+ provides the substrate for electron transport; and MOTS-c provides the upstream metabolic signalling that optimises how cells respond to energy demands. Together they represent a comprehensive mitochondrial support protocol.